Back to Search
Start Over
927TiP SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) + tiragolumab (Tira) and atezo + placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+ squamous cell carcinoma of the head and neck (SCCHN)
- Source :
- Annals of Oncology. 32:S814-S815
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
Details
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........6ec64611a7e9253527c254cf04f9dae6